- Home
- AXSM vs AB Comparison
AXSM vs AB Comparison
Compare AXSM & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXSM | AB |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 3.6B |
| IPO Year | 2015 | 1988 |
Fundamental Metrics
Financial Performance| Metric | AXSM | AB |
|---|---|---|
| Price | $148.16 | $40.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 5 |
| Target Price | ★ $176.00 | $42.00 |
| AVG Volume (30 Days) | ★ 526.6K | 225.0K |
| Earning Date | 11-03-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 8.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.03 |
| Revenue | ★ $561,263,000.00 | N/A |
| Revenue This Year | $66.20 | N/A |
| Revenue Next Year | $57.56 | $8.41 |
| P/E Ratio | ★ N/A | $13.17 |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $32.28 |
| 52 Week High | $152.94 | $43.30 |
Technical Indicators
Market Signals| Indicator | AXSM | AB |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 47.53 |
| Support Level | $144.00 | $40.26 |
| Resistance Level | $150.00 | $41.37 |
| Average True Range (ATR) | 4.15 | 0.87 |
| MACD | -0.73 | -0.11 |
| Stochastic Oscillator | 57.42 | 21.16 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (42%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of July 2025, the company had $829 billion in managed assets, composed primarily of fixed-income (36% of AUM) and equity (42%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.